E-mail us: service@prospectnews.com Or call: 212 374 2800
Bank Loans - CLOs - Convertibles - Distressed Debt - Emerging Markets
Green Finance - High Yield - Investment Grade - Liability Management
Preferreds - Private Placements - Structured Products
 
Published on 4/6/2015 in the Prospect News PIPE Daily.

AntriaBio raises $2 million through private placement of equity units

Units of one common share and one three-year warrant sold in offering

By Devika Patel

Knoxville, Tenn., April 6 – AntriaBio, Inc. sold about $2 million of its units in a private placement on March 31, according to an 8-K filed Monday with the Securities and Exchange Commission.

The company sold units of one common share and one warrant at $1.85 per unit. Each warrant is exercisable at $2.50 for three years. The strike price is a 38.89% premium to the March 30 closing share price of $1.80.

The biopharmaceutical company is based in Menlo Park, Calif.

Issuer:AntriaBio, Inc.
Issue:Units of one common share and one warrant
Amount:$2 million
Price:$1.85
Warrants:One warrant per unit
Warrant expiration:Three years
Warrant strike price:$2.50
Settlement date:March 31
Stock symbol:OTCBB: ANTB
Stock price:$1.80 at close March 30
Market capitalization:$37.63 million

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.